Pharmacogenetics and anaesthesia: the value of genetic profiling
Approximately 50 years ago, pharmacogenetics was described as a new field of medicine
that may explain human drug action. Anaesthesia played a key role in the early …
that may explain human drug action. Anaesthesia played a key role in the early …
Genetic polymorphisms in ADRB2 and ADRB1 are associated with differential survival in heart failure patients taking β-blockers
LA Guerra, C Lteif, MJ Arwood… - The …, 2022 - nature.com
Single nucleotide polymorphisms (SNPs) have been associated with differential beta-
blocker (BB) effects on heart rate, blood pressure, and left ventricular ejection fraction in …
blocker (BB) effects on heart rate, blood pressure, and left ventricular ejection fraction in …
Association of common polymorphisms in β1-adrenergic receptor with antihypertensive response to carvedilol
D Si, J Wang, Y Xu, X Chen, M Zhang… - Journal of …, 2014 - journals.lww.com
Objectives: Marked interpatient variability exists in the blood pressure response to
carvedilol, a nonselective β-blocker. Here we evaluated the influence of 4 common …
carvedilol, a nonselective β-blocker. Here we evaluated the influence of 4 common …
Studies on the Interactions between β2 Adrenergic Receptor and Gs Protein by Molecular Dynamics Simulations
The β2 adrenergic receptor (β2AR) plays a key role in the control of smooth muscle
relaxation in airways, the therapy of asthma, and a series of other basic physiological …
relaxation in airways, the therapy of asthma, and a series of other basic physiological …
Genetic polymorphisms associated with heart failure: A literature review
M Guo, G Guo, X Ji - Journal of International Medical …, 2016 - journals.sagepub.com
Objective To review possible associations reported between genetic variants and the risk,
therapeutic response and prognosis of heart failure. Methods Electronic databases …
therapeutic response and prognosis of heart failure. Methods Electronic databases …
Pharmacogenetics in chronic heart failure: new developments and current challenges
JA Talameh, DE Lanfear - Current heart failure reports, 2012 - Springer
The individual patient responses to chronic heart failure (HF) pharmacotherapies are highly
variable. This variability cannot be entirely explained by clinical characteristics, and genetic …
variable. This variability cannot be entirely explained by clinical characteristics, and genetic …
[HTML][HTML] Genetic polymorphisms in ADRB1, ADRB2 and CYP2D6 genes and response to beta-blockers in patients with acute coronary syndrome
C Castaño-Amores, A Antúnez-Rodríguez… - Biomedicine & …, 2023 - Elsevier
Betablockers (BBs) are prescribed for ischaemia in patients with acute coronary syndrome
(ACS). In Spain, bisoprolol and carvedilol are the most prescribed BBs, but patients often …
(ACS). In Spain, bisoprolol and carvedilol are the most prescribed BBs, but patients often …
[HTML][HTML] Impact of the β-1 adrenergic receptor polymorphism on tolerability and efficacy of bisoprolol therapy in Korean heart failure patients: association between β …
HY Lee, WJ Chung, HK Jeon, HS Seo… - The Korean Journal …, 2016 - ncbi.nlm.nih.gov
Methods: One hundred patients with stable CHF (left ventricular ejection fraction [LVEF]<
45%) were enrolled. Enrolled patients started 1.25 mg bisoprolol treatment once daily, then …
45%) were enrolled. Enrolled patients started 1.25 mg bisoprolol treatment once daily, then …
The “missing” link between acute hemodynamic effect and clinical response
FW Prinzen, A Auricchio - Journal of cardiovascular translational research, 2012 - Springer
The hemodynamic, mechanical and electrical effects of cardiac resynchronization therapy
(CRT) occur immediate and are lasting as long as CRT is delivered. Therefore, it is …
(CRT) occur immediate and are lasting as long as CRT is delivered. Therefore, it is …
Variants in ADRB1 and CYP2C9: association with response to atenolol and losartan in Marfan syndrome
SL Van Driest, LA Sleeper, BD Gelb, SA Morris… - The Journal of …, 2020 - Elsevier
Objective To test whether variants in ADRB1 and CYP2C9 genes identify subgroups of
individuals with differential response to treatment for Marfan syndrome through analysis of …
individuals with differential response to treatment for Marfan syndrome through analysis of …